Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34779049

about

Herbal medicines and nonalcoholic fatty liver disease Hepatitis C Virus, Insulin Resistance, and Steatosis Genetic background in nonalcoholic fatty liver disease: A comprehensive review Endocrine causes of nonalcoholic fatty liver disease Metabolic aspects of adult patients with nonalcoholic fatty liver disease Long Noncoding RNAs in Metabolic Syndrome Related Disorders Inhibitory effects of Doenjang, Korean traditional fermented soybean paste, on oxidative stress and inflammation in adipose tissue of mice fed a high-fat diet.Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease.Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease.Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease.Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms.Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice.Systems Vaccinology: Applications, Trends, and Perspectives.Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns Study.Emerging role of exosomes in liver physiology and pathology.Obesity and Liver Cancer.TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions.New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Adipokines in Liver Cirrhosis.Therapeutic effect of flax-based diets on fatty liver in aged laying hens Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway.The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice.Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis.Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis.The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus.Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats.Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis.Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features.Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study.

P2860

Q26738524-88B85FAF-69DE-41C2-B130-D7FF247CF5B3 Q26751755-CAABD353-48AF-410E-B9CB-632F9937BAFF Q26780248-9CA7C1AF-7729-4229-9EE3-BA36AC96A547 Q26780254-FB734354-F55D-4B41-8F8F-CD8F0A69A85C Q28067490-621E2FE0-16E7-4131-A425-BA979FBCC6F4 Q28073491-E0FEEED8-3F36-4671-BC9D-33C068C12DBF Q35696782-9106C844-1C2D-449C-B5B0-5F65BB6BF6BE Q35858593-B654B3AD-E6C8-4E28-AA72-A621BCAC5603 Q36005098-E5750B2E-20B4-4704-ADC6-F7D45E0BB3D5 Q36282638-20C3296D-4B7C-4DDC-AADE-2E7A61D1086C Q36318134-79908C6D-C078-4880-9C42-B88FCA1A6C64 Q37246571-8142186C-03F1-4C4E-AA3E-5A6BE727A06B Q37248828-E48D0479-603D-4A07-AD83-892431EC3A0F Q37533461-6D6881FE-0777-4008-AF7B-AEF1D3F3F505 Q37561108-4FDD39BD-22EA-4E79-98B0-928015801AD7 Q38642318-0EF1CB03-E409-4294-A70B-DC6E8F931B8D Q38656435-5143DBE1-0994-4BCE-9416-2E956C74E6B1 Q38665591-713F57CA-4EAB-4359-8B7C-7564AE399169 Q38687860-AD2EE69A-3D17-4911-95C6-90EF6F8DC05B Q38807837-9DF09194-B07C-4625-9940-EE8474D92172 Q38819558-A8C1D666-A97E-4ADE-9EDB-AC2B0CBCEC7C Q38928900-3C3CC39D-35E6-45D6-BAEA-DBB7C903088C Q38931228-496926D5-B493-4066-A2BF-1FADBEC4F739 Q39026668-2025368D-F1DB-420E-A1FF-E889AAFF60C9 Q39174269-6AC6B396-B4A1-409B-89DB-C4FCF84B4037 Q39393326-B96B724F-7CB8-45CB-A429-83A99F48296B Q39404643-9ED390FF-F44F-44F3-9947-0645CD5D884E Q39796475-FC6B81BA-CE90-49E2-9C52-90F759655DFD Q40104945-2360B3CA-B3D7-4EBE-923A-AE3A53C10ECD Q40408671-8A03CE1B-B602-4990-88C7-D4FA4AF7ED0B Q40545494-EA9D9B37-DCB7-4F48-92FD-5DBCD2AD40DE Q41361264-77157B4C-ACFA-41E5-8AC7-44597CF34396 Q41431733-70C59666-99D0-4FB1-9831-7D92B1114C4B Q41449920-D9A8542E-8E73-4718-AC2C-DAD4391F0247 Q41500577-42040146-4AD1-4AB6-AAB3-5E8499E17492 Q41722812-B7A403DE-4200-4B20-8346-17E2DE155364 Q46468344-C84569CE-98E4-4803-9799-F7F1D4AD6315 Q47353110-B0CF34F3-F8BD-4C01-84B4-E1A8F438F767 Q47662104-BB47989B-6715-4ADC-AF1F-824773E9CCE5 Q47746064-CA387C63-5839-4861-A51E-6CD1B696A422

P2860

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34779049

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@ast

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@en

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@nl

type

label

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@ast

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@en

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@nl

prefLabel

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@ast

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@en

Adipokines and proinflammatory ...... alcoholic fatty liver disease.

@nl

P1433

Q34779049-401124C9-BDB0-4D8E-A6FE-AB65C1EA556D

P1476

Q34779049-A183A9B9-09CE-4CB4-BC90-A1805AFF6D98

P2093

Q34779049-5307F45F-9FB2-457B-AB17-7D6377EBE84B

Q34779049-71E4A1F7-98FC-4A1A-B09D-BD8D1538721A

Q34779049-95C1C41A-6FEF-4261-B45B-128736191752

Q34779049-A5AE3B22-8200-4DC1-AA13-D3AB58D59361

P2860

Q34779049-00BC65A2-3BC8-4C14-9861-62C22A9E3AEE

Q34779049-04405772-D078-47FF-A3C4-45F636967495

Q34779049-050A0A87-674E-407B-8F03-BBE4B1188320

Q34779049-061206E9-415D-4A0D-BCA7-4B33AB36E26A

Q34779049-06883200-694E-43DD-882E-496CC65EC13D

Q34779049-06B50974-BD25-405C-98A8-AEC471BCF97F

Q34779049-0752448F-8010-4633-99EA-0F78CDB54105

Q34779049-08470C74-1A88-403E-BD25-E8A33481E60C

Q34779049-08BF6CEB-7FBA-4338-9AE6-05386D7A91FA

Q34779049-08EDB4E2-E358-4567-94ED-2B9EDB3C3EBA

P304

Q34779049-B42B4AB3-E4C2-4033-9882-A9FA7D8D095C

P31

Q34779049-DEF75869-4299-4A0F-9EAD-C28056A4C7A9

P356

Q34779049-0C5E222D-1E20-49EA-81B5-022C94FE2425

P407

Q34779049-094DD63B-6F37-4949-8FEA-51B812B47542

P433

Q34779049-E749227C-2A0E-4BC6-BC51-64F9D12D6112

P478

Q34779049-FDB82A94-EFE5-46EF-AB8D-AD6809BB27A8

P50

Q34779049-2082FD73-C720-4093-BA9D-9505D79A7FCA

P577

Q34779049-6F49C5B2-C07B-4F09-9A78-187FC2F3DE52

P5875

Q34779049-AB73E9FC-56CC-4216-98D9-B7F8ED9021F9

P698

Q34779049-445BB78E-66FA-4F10-85FC-37940C2BFABB

P932

Q34779049-CD2D3865-FDCE-47A2-B18C-4A8384765C45

P356

WJG.V20.I48.18070

P1433

World Journal of Gastroenterology

P1476

Adipokines and proinflammatory ...... nalcoholic fatty liver disease

@en

P2093

Lea Smirčić Duvnjak

http://www.w3.org/2001/XMLSchema#string

Lucija Virović Jukić

http://www.w3.org/2001/XMLSchema#string

Marija Gomerčić Palčić

http://www.w3.org/2001/XMLSchema#string

Sanja Stojsavljević

http://www.w3.org/2001/XMLSchema#string

P2860

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

A family of tissue-specific resistin-like molecules

Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Retinol-binding protein 4 in human obesity

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting

Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity

P304

18070-18091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I48.18070

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270651508

http://www.w3.org/2001/XMLSchema#string

P698

25561778

http://www.w3.org/2001/XMLSchema#string

P932

4277948

http://www.w3.org/2001/XMLSchema#string